1. D. Hull-Nye, T. Meadows, S.R. Smith?, E.J. Schwartz, Key factors and parameter ranges for immune control of equine infectious anemia virus infection (Viruses, 2023, 15, 691)

  2. M. Haque, F. Al Basir, E. Venturino, A. Saeed, S.R. Smith?, Mathematical modelling of clonorchiasis with human treatment and fish vaccination versus snail control (Chaos, Solitons and Fractals in press)

  3. Y. Xue, D. Chen, S.R. Smith?, X. Ruan, S. Tang, Coupling the within-host process and between-host transmission of COVID-19 suggests vaccination and school closures are critical (Bulletin of Mathematical Biology, 2023, 85, Article 6)

  4. E.J. Schwartz, C. Costris-Vas, S.R. Smith?, Modelling mutation in equine infectious anemia virus infection suggests a path to viral clearance with repeated vaccination (Viruses, 2021, 13, 2450)

  5. I. Yadegari, M. Omidi, S.R. Smith?, The herd-immunity threshold must be updated for multi-vaccine strategies and multiple variants (Scientific Reports, 2021, 11:22970)

  6. S. Wiafe, S.R. Smith?, We must reckon with the history of medical racism and violence in order to address vaccine hesitancy in African, Caribbean, Black and Indigenous communities (Institute for Science, Society and Policy, February 22, 2021)

  7. S.M.C. Abo, S.R. Smith?, Is a COVID-19 vaccine likely to make things worse? (Vaccines, 2020, 8(4), 761)

  8. C. Costris-Vas, E.J. Schwartz, R.J. Smith?, Predicting COVID-19 using past pandemics as a guide: how reliable were mathematical models then, and how reliable will they be now? (Mathematical Biosciences and Engineering, 2020, 17(6), 7502-7518)

  9. S.M.C. Abo, R.J. Smith?, Modelling the daily risk of Ebola in the presence and absence of a potential vaccine (Infectious Disease Modelling, 2020, 5, 905-917)

  10. S. Mosher, C. Costris-Vas, R.J. Smith?, Modelling the Effects of Stigma on Leprosy (in: Mathematical Analysis and Application in Modelling, P. Roy, X. Cao, X.-Z. Li, P. Das, S. Deo, eds, Springer, 2020, 53-68)

  11. S. Saha, P.K. Roy, R.J. Smith?, Modelling monocyte-derived dendritic cells as a therapeutic vaccine against HIV (Journal of Biological Systems, 2018, 26(4), 1-23)

  12. S. Zhang, H. Guo, R.J. Smith?, Dynamical Analysis for a Hepatitis B Transmission Model with Immigration and Infection Age (Mathematical Biosciences and Engineering, 2018, 15(6), 1291-1313)

  13. R.J. Smith?, A.B. Hogan, G.N. Mercer, Unexpected infection spikes in a model of Respiratory Syncytial Virus vaccination (Vaccines, 2017, 5:12)

  14. Y. Samia, A.D. Kealey, R.J. Smith?, A Mathematical Model of a Theoretical Sleeping Sickness Vaccine (Mathematical Population Studies, 2016, 23(2), 95-122)

  15. R.J. Smith?, An easy way to speed up the eradication of polio (Pi in the Sky, 2015, 19, 19-23)

  16. C. Browne, R.J. Smith?, L. Bourouiba, From regional pulse vaccination to global disease eradication: insights from a mathematical model of Poliomyelitis (Journal of Mathematical Biology, 2015, 71(1), 215-253)

  17. C. Rogers, R.J. Smith?, Examining provincial HPV vaccination schemes in Canada: should we standardise the grade of vaccination or the number of doses? (International Scholarly Research Notices, 2015, Article ID 170236)

  18. R.J. Smith?, J. Li, J Mao, B. Sahai, Using within-host mathematical modelling to predict the long-term outcome of human papillomavirus vaccines (Canadian Applied Mathematics Quarterly, 2015, 21(2), 281-299)

  19. E.J. Schwartz, R.J. Smith?, Identifying the conditions under which antibodies protect against infection by Equine Infectious Anemia Virus (Vaccines, 2014, 2(2), 397-421)

  20. N.S. Chong, J.M. Tchuenche, R.J. Smith?, A mathematical model of avian influenza with half-saturated incidence (Theory in Biosciences, 2014, 133, 23-38)

  21. K.-F. Gee, K. Addison and R.J. Smith?, Modelling the impact of a live virus vaccine for Tularemia (In: Understanding the dynamics of emerging and re-emerging infectious diseases using mathematical models, S. Mushayabasa and C.P. Bhunu, eds, 2012, pp23-48)

  22. M. Al-arydah and R.J. Smith?, An age-structured model of human papillomavirus vaccination (Mathematics and Computers in Simulation 2011, 82(3), 629-642)

  23. B.P. Konrad, N. Vaidya and R.J. Smith?, Modelling mutation to a cytotoxic T-lymphocyte HIV vaccine (Mathematical Population Studies, 2011, 18(2), 122-149)

  24. J.M. Tchuenche, N. Dube, C.P. Bhunu, R.J. Smith? and C.T. Bauch, The impact of media coverage on the transmission dynamics of human influenza (BMC Public Health 2011, 11(Suppl 1):S5)

  25. M. Llamazares, R.J. Smith?, Evaluating human papillomavirus vaccination programs in Canada: should provincial healthcare pay for voluntary adult vaccination? (BMC Public Health 2008, 8:114)

  26. R.J. Smith?, E.J. Schwartz, Predicting the potential impact of a cytotoxic T-lymphocyte HIV vaccine: how often should you vaccinate and how strong should the vaccine be? (Mathematical Biosciences 2008, 212, 180-187)

  27. R.J. Smith?, Could low-efficacy malaria vaccines increase secondary infections in endemic areas? (In: Mathematical Modeling of Biological Systems, Volume II 2007, A. Deutsch, R. Bravo de la Parra, R. de Boer, O. Diekmann, P. Jagers, E. Kisdi, M. Kretzschmar, P. Lansky and H. Metz (eds). Birkhauser, Boston, 3-10)

  28. S.M. Blower and R.J. Smith, Is population-level perversity a likely outcome of mass vaccination against HIV? - Authors' reply. (The Lancet Infectious Diseases, Vol 5 2005 255-256)

  29. R.J. Smith and S.M. Blower, Could disease-modifying HIV vaccines cause population-level perversity? (The Lancet Infectious Diseases, Vol 4 2004 pp 636-639)